Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib

Phase 1

Completed

Conditions: Lung Cancer

Interventions: Drug: Ruxolitinib
Drug: Erlotinib

First Posted Date: 2014-06-04

Last Posted Date: 2019-01-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT02155465

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Cancer Center at Phelps, Sleepy Hollow, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 3 locations

Development of Psychotherapeutic Interventions for Parents Who Lost a Child

Not Applicable

Active, not recruiting

Conditions: Parents Who Have Lost a Child

Interventions: Behavioral: Meaning-Centered Grief Therapy (MCGT)
Behavioral: questionnaires assessments
Behavioral: Supportive Psychotherapy (SP)

First Posted Date: 2014-06-03

Last Posted Date: 2024-07-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 108

Registration Number: NCT02153619

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Phase 3

Completed

Conditions: Bladder Cancer

Interventions: Other: standard fluid management
Other: fluid management guided by the EV1000

First Posted Date: 2014-05-23

Last Posted Date: 2024-03-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 282

Registration Number: NCT02145871

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York, United States

and more 2 locations

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Not Applicable

Completed

Conditions: Ovarian Cancer

Interventions: Procedure: PET/CT Scan
Procedure: MRI

First Posted Date: 2014-05-22

Last Posted Date: 2020-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 26

Registration Number: NCT02144311

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States

Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers with the BRAF Inhibitor Vemurafenib: a Pilot Study

Not Applicable

Completed

Conditions: Thyroid Carcinoma

Interventions: Drug: Vemurafenib
Device: serial 124I PET/CT
Drug: thyrotropin alpha

First Posted Date: 2014-05-22

Last Posted Date: 2024-11-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT02145143

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Not Applicable

Withdrawn

Conditions: Histologically-confirmed Malignancies

Interventions: Radiation: [18F] FLT
Device: PET/CT scans

First Posted Date: 2014-05-15

Last Posted Date: 2019-09-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT02139150

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Phase 2

Completed

Conditions: CMV Infection
Persistent CMV Viremia

Interventions: Biological: CMVpp65 Specific T-cells

First Posted Date: 2014-05-13

Last Posted Date: 2024-10-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 77

Registration Number: NCT02136797

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma

Not Applicable

Active, not recruiting

Conditions: Cutaneous Basal Cell
Squamous Cell Carcinoma

Interventions: Radiation: Electronic Skin Surface Brachytherapy
Behavioral: Quality of life assessment

First Posted Date: 2014-05-06

Last Posted Date: 2024-06-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 36

Registration Number: NCT02131805

Locations: 🇺🇸
Memorial Sloan Kettering Commack (Consent only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
🇺🇸
Boca Raton Regional Hospital, Boca Raton, Florida, United States

and more 5 locations

Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Phase 1

Completed

Conditions: Primary Peritoneal Cancer
Ovarian Cancer
Fallopian Tube Cancer

Interventions: Drug: Paclitaxel,
Drug: Bevacizumab
Drug: Cisplatin
Drug: Olaparib

First Posted Date: 2014-04-24

Last Posted Date: 2020-08-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT02121990

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History

Active, not recruiting

Conditions: Breast Cancer Survivors

First Posted Date: 2014-04-24

Last Posted Date: 2024-12-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 499

Registration Number: NCT02122107

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
City of Hope, Duarte, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy